173
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Effectiveness of Game-Based Meditation Therapy for Adolescents with Posttraumatic Symptoms in Residential Care: A Randomized Controlled Trial

, , , &
 

ABSTRACT

Many adolescents in residential care have experienced traumatic events and suffer from posttraumatic stress. This study examined the effectiveness of Muse, a game-based meditation intervention played with guidance, as an addition to treatment as usual (TAU) for adolescents with posttraumatic symptoms in residential care. Seventy-seven adolescents with posttraumatic symptoms (10–18 years old) received either Muse and TAU (n = 37) or treatment as usual (n = 40). TAU consisted of evidence-based treatments that did not specifically target posttraumatic symptoms. Outcomes were measured at T1, T2, and two-months follow-up (FU). Primary outcomes were posttraumatic symptoms (self-report and mentor-report) and stress (self-report) at T2. The Muse group showed significantly greater improvements than the control group at T2 regarding self-reported posttraumatic symptoms, stress, anxiety, depression, and aggression. Mentor reports showed marginally significant decreases in posttraumatic stress at T2. There were no differences between the groups at FU, except for a marginally significant difference in self-reported posttraumatic symptoms, where the Muse participants showed larger decreases. This study showed that game-based meditation therapy is a promising intervention that is more effective than TAU alone. Yet, further studies on its immediate and long-term effects, and mechanisms of change are warranted. Implications are discussed.

Acknowledgments

The authors wish to thank the Dr. Couvee Fonds and the Innovatiefonds Zorgverzekeraars for funding this study and the participants, group care workers and research assistants for their invaluable contribution.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The work was supported by the Innovatiefonds Zorgverzekeraars [NA]; Dr. Couvee Fonds [NA].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.